. Author manuscript; available in PMC: 2020 Sep 1.

Published in final edited form as: J Ren Nutr. 2019 Jan 21;29(5):428–437. doi: 10.1053/j.jrn.2018.11.002

Table 1.

Patient Characteristics at Baseline

Demographic Characteristics	Study Cohort (N = 530)
Age (years)	54.5 [17]
Dialysis vintage (months)	45.3 [55.2]
Body mass index (kg/m²)	29.8 [10.7]
Female, n (%)	213 (40.2%)
Race, n (%)^*
Black/African American	217 (40.9%)
White	284 (53.6%)
Other	29 (5.5%)
Hispanic/Latino, n (%)^*	87 (16.4%)
Primary cause of renal failure, n (%)
Diabetes mellitus	211 (39.8%)
Hypertension	176 (33.2%)
Glomerulonephritis	43 (8.1%)
Polycystic kidney	16 (3%)
Other	66 (12.5%)
Unknown	18 (3.4%)
Diabetes mellitus, n (%)	304 (57.4%)
Congestive heart failure, n (%)	109 (20.6%)
Phosphate binder at baseline, n (%)
Sevelamer	317 (59.8%)
Calcium acetate	146 (27.6%)
Lanthanum carbonate	42 (7.9%)
Magnesium carbonate	2 (0.4%)
Other^†	23 (4.3%)

Values are presented as median [interquartile range], or n (%).

Race/ethnicity was self-reported.

^†

Includes patients who switched between sevelamer, calcium acetate, and/or lanthanum carbonate at baseline.